AIDA — Aida Pharmaceuticals Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Aida Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2003 December 31st	R2004 December 31st	2005 December 31st	C2006 December 31st	2007 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10KSB	10KSB	10KSB	10KSB	10KSB
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.017	1.64	1.47	1.45	2.74
Depreciation
Deferred Taxes
Non-Cash Items	0	-2.35	1.89	2.35	1.61
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.017	-2.54	1.07	-2.73	2.14
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	0	-2.52	6.12	2.66	8.39
Capital Expenditures	—	-1.16	-0.7	-2.97	-3.61
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0	-0.994	-4.08	-1.41	-8.14
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	0	-2.16	-4.78	-4.38	-11.8
Financing Cash Flow Items	0	5.55	-4.24	0.042	1.2
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	0	4.98	-1.17	4.43	5.02
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	—	0.295	0.32	2.99	2.28